• 1
    Østergaard SD, Meyers BS, Flint AJ et al. Measuring psychotic depression. Acta Psychiatr Scand 2014;129:211–220.
  • 2
    Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278296.
  • 3
    Bech P, Gram LF, Dein E, Jacobsen O, Vitger J, Bolwig TG. Quantitative rating of depressive states. Acta Psychiatr Scand 1975;51:161170.
  • 4
    Bech P, Allerup P, Gram LF et al. The Hamilton depression scale. Evaluation of objectivity using logistic models. Acta Psychiatr Scand 1981;63:290299.
  • 5
    Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799812.
  • 6
    O'Sullivan RL, Fava M, Agustin C, Baer L, Rosenbaum JF. Sensitivity of the six-item Hamilton Depression Rating Scale. Acta Psychiatr Scand 1997;95:379384.
  • 7
    Faries D, Herrera J, Rayamajhi J, Debrota D, Demitrack M, Potter WZ. The responsiveness of the Hamilton Depression Rating Scale. J Psychiatr Res 2000;34:310.
  • 8
    Arfken C, Balon R. Another look at outcomes and outcome measures in psychiatry: Cui bono? Psychother Psychosom 2014;83:6–9.
  • 9
    Rush AJ, Warden D, Wisniewski SR et al. STAR*D: revising conventional wisdom. CNS Drugs 2009;23:627647.
  • 10
    Gaynes B, Warden D, Trivedi M, Wisniewski S, Fava M, Aj Rush AJ. What did STAR* D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv 2009;60:14391445.
  • 11
    Tedlow J, Fava M, Uebelacker L, Nierenberg AA, Alpert JE, Rosenbaum J. Outcome definitions and predictors in depression. Psychother Psychosom 1998;67:266270.
  • 12
    Fava M, Evins AE, Dorer DJ, Schoenfeld DA. The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach. Psychother Psychosom 2003;72:115127.